Dr. Jean Claude Bassila, MD

Dr. Bassila practices at Fmc Dialysis of Santa Rosa in Fullerton, California.

Dr. Bassila's NPI, 1487817854, was assigned on July 7, 2008. Dr. Bassila graduated from American University of Beirut Faculty of Medicine in 2006. Dr. Bassila holds California license A145695.

Dr. Bassila's primary practice is Fmc Dialysis of Santa Rosa, at 279 E Imperial Hwy, Fullerton, CA 92835 in Orange County. The practice phone is (707) 527-5350.

Dr. Bassila's primary practice is Fmc Dialysis of Santa Rosa in Fullerton, California. Dr. Bassila is also affiliated with Providence Santa Rosa Memorial Hospital. The medical group on file is TeleMed2U. Dmand AI also links Dr. Bassila to 6 more hospitals, 6 medical groups, 2 dialysis centers, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bassila practices, 12 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bassila's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bassila is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bassila's licenses on file in 7 states: California, Georgia, Oregon, Mississippi, Nevada, Arkansas and Ohio.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and parathyroid gland disorder among the conditions Dr. Bassila treats.

CMS data shows 5,137 Medicare services from Dr. Bassila across 19 procedure codes in 2024, for 325 Medicare patients. Medicare paid $316,503 for them.

CMS counts 325 Medicare patients who saw Dr. Bassila in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bassila's median patient age at 71, with 48% women.

In 2024, Dr. Bassila wrote 774 Medicare Part D claims for 151 patients. 86% of them were for generic drugs. CMS names the drug for 561 of them, across 22 drugs with 11 or more claims each, at $163,636 in total drug cost. In 2023, CMS named 542 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bassila for performance year 2024, reported individually. Dr. Bassila accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bassila as offering telehealth.

CMS Open Payments shows 17 general payments to Dr. Bassila from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Fresenius USA Marketing, Inc. paid the most, $3,810.

Dr. Bassila graduated from American University of Beirut Faculty of Medicine in 2006.

Dr. Bassila is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.